1,239 results on '"Fendrick, A. Mark"'
Search Results
152. Coronary artery bypass grafting in Native Americans: A higher risk of death compared to other ethnic groups?
153. Influenza: Cost of Illness and Considerations in the Economic Evaluation of New and Emerging Therapies
154. Helicobacter pylori and NSAID gastropathy: An ambiguous association
155. The Impact of Expanding Pre-Deductible Coverage in HSA-Eligible Health Plans on Premiums.
156. Utilization Impact of Cost-Sharing Elimination for Preventive Care Services: A Rapid Review.
157. Implantable or External Defibrillators for Individuals at Increased Risk of Cardiac Arrest: Where Cost-Effectiveness Hits Fiscal Reality
158. Prophylactic pacemaker use to allow β-blocker therapy in patients with chronic heart failure with bradycardia
159. Developments in Influenza Prevention and Treatment: A Managed Care Perspective
160. Informal caregiving for diabetes and diabetic complications among elderly Americans
161. Payer type and the returns to bypass surgery: evidence from hospital entry behavior
162. Comparing Local and Regional Variation in Health Care Spending
163. The Evaluation of Distal Symmetric Polyneuropathy: A Physician Survey of Clinical Practice
164. Value-based insurance design: more health at any price
165. Cost-Utility of Aspirin and Proton Pump Inhibitors for Primary Prevention
166. Contributions Of Public Health, Pharmaceuticals, And Other Medical Care To US Life Expectancy Changes, 1990-2015
167. Waste in the Medicare Program: a National Cross-Sectional Analysis of 2017 Low-Value Service Use and Spending
168. The Need to Expand Coverage and Enhance Access to Essential Services on a Predeductible Basis Following COVID-19
169. Su1773 MORE FECAL IMMUNOCHEMICAL TESTS ARE NEEDED TO MATCH THE CLINICAL BENEFIT OF EQUIVALENT NUMBERS OF MULTITARGET STOOL DNA TESTS: CRC-AIM MICROSIMULATION MODEL RESULTS
170. Tu1822 HIGHER IMPACT ON CLINICAL OUTCOMES FROM DELAYS IN COLORECTAL CANCER SCREENING WITH THE FECAL IMMUNOCHEMICAL TEST VS MULTITARGET STOOL DNA: CRC-AIM MICROSIMULATION MODEL RESULTS
171. Mo1598 ESTIMATING THE IMPACT OF IMPERFECT ADHERENCE TO STOOL-BASED COLORECTAL CANCER SCREENING STRATEGIES ON COMPARATIVE EFFECTIVENESS USING THE CRC-AIM MICROSIMULATION MODEL
172. Sa1658 MICROSIMULATION STUDY OF LIFE-YEARS GAINED FROM SCREENING VERSUS FOLLOW-UP COLONOSCOPY USING THE CRC-AIM MODEL
173. The Changing Health Insurance Coverage Landscape in the United States
174. Description and Validation of the Colorectal Cancer and Adenoma Incidence & Mortality (CRC-AIM) Microsimulation Model
175. How Would Low-Income Communities Prioritize Medicaid Spending?
176. Out-Of-Pocket Spending For Maternity Care Among Women With Employer-Based Insurance, 2008–15
177. Value added radiology: Using existing radiology services to improve cancer screening
178. Associations in breast and colon cancer screening behavior in women 1
179. Colorectal cancer screening behavior in women attending screening mammography: Longitudinal trends and predictors
180. Tailoring Complex Care to Patients' Needs: Myths, Realities, and Best Next Steps.
181. The Utilization and Costs of Grade D USPSTF Services in Medicare, 2007–2016.
182. Cost-effectiveness of Proton Pump Inhibitor Cotherapy in Patients Taking Long-term, Low-Dose Aspirin for Secondary Cardiovascular Prevention
183. Value and Increased Cost Sharing in the American Health Care System
184. Timing and Timeliness in Medical Care Evaluation
185. Defining Cause of Death in Stroke Patients: The Brain Attack Surveillance in Corpus Christi Project
186. The Future of Health Economic Modeling: Have We Gone Too Far or Not Far Enough?
187. Medicare Coverage of Angiotensin-Converting Enzyme Inhibitors
188. The effects of a professionally produced videotape on education and anxiety/distress levels for patients with newly diagnosed melanoma: A randomized, prospective clinical trial
189. Cost-Effectiveness of Full Medicare Coverage of Angiotensin-Converting Enzyme Inhibitors for Beneficiaries with Diabetes
190. Primary-Care Physiciansʼ Perceptions and Practices on the Management of GERD: Results of a National Survey
191. Out-of-Pocket Health-Care Expenditures among Older Americans with Cancer
192. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
193. Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population
194. Informed Choices in Anti-Inflammatory Drug Therapy: Why Patient Risk Matters
195. Employer Uptake of Pre-Deductible Coverage for Preventive Services in HSA-Eligible Health Plans.
196. Extent and Cost of Informal Caregiving for Older Americans With Symptoms of Depression
197. What Is the Price of Life and Why Doesnʼt It Increase at the Rate of Inflation?
198. The Impact of a Celebrity Promotional Campaign on the Use of Colon Cancer Screening: The Katie Couric Effect
199. Use of Pharmacoeconomics Information—Report of the ISPOR Task Force on Use of Pharmacoeconomic/Health Economic Information in Health-Care Decision Making
200. The Impact of Including Passive Benefits in Cost-Effectiveness Analysis: The Case of Automated External Defibrillators on Commercial Aircraft
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.